PGx medication risk prediction model

This algorithm predicts those who are going to be exposed to warfarin, simvastatin, or clopidogrel as three medications that have known pharmacogenomic influences.  This algorithm was used to select individuals for the Vanderbilt PREDICT (Pharmacogenomic Resource for Enhanced Decisions in Care & Treatment) program, which prospectively tests individuals at risk of needing medications whose efficacy is effected by genetic variants.  


For more information on PREDICT, see

Phenotype ID: 
Do Not List on the Collaboration Phenotypes List
Phenotype Attributes: 
Jonathan Schildcrout and Josh Denny
Contact Author: 

Suggested Citation

Jonathan Schildcrout and Josh Denny. Vanderbilt University. PGx medication risk prediction model. PheKB; 2012 Available from:

PubMed References